206 related articles for article (PubMed ID: 34825181)
1. A primer on harnessing non-enzymatic post-translational modifications for drug design.
Long MJC; Ly P; Aye Y
RSC Med Chem; 2021 Nov; 12(11):1797-1807. PubMed ID: 34825181
[TBL] [Abstract][Full Text] [Related]
2. Privileged Electrophile Sensors: A Resource for Covalent Drug Development.
Long MJC; Aye Y
Cell Chem Biol; 2017 Jul; 24(7):787-800. PubMed ID: 28648380
[TBL] [Abstract][Full Text] [Related]
3. An Oculus to Profile and Probe Target Engagement In Vivo: How T-REX Was Born and Its Evolution into G-REX.
Long MJC; Rogg C; Aye Y
Acc Chem Res; 2021 Feb; 54(3):618-631. PubMed ID: 33228351
[TBL] [Abstract][Full Text] [Related]
4. Targeted Covalent Inhibitors for Drug Design.
Baillie TA
Angew Chem Int Ed Engl; 2016 Oct; 55(43):13408-13421. PubMed ID: 27539547
[TBL] [Abstract][Full Text] [Related]
5. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins.
Yang Y; Shu YZ; Humphreys WG
Chem Res Toxicol; 2016 Jan; 29(1):109-16. PubMed ID: 26675335
[TBL] [Abstract][Full Text] [Related]
6. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
7. Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases.
Zhu Y; Hu X
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296718
[TBL] [Abstract][Full Text] [Related]
8. Getting the Right Grip? How Understanding Electrophile Selectivity Profiles Could Illuminate Our Understanding of Redox Signaling.
Long MJC; Wang L; Aye Y
Antioxid Redox Signal; 2020 Nov; 33(15):1077-1091. PubMed ID: 31578876
[No Abstract] [Full Text] [Related]
9. Covalent Docking in Drug Discovery: Scope and Limitations.
Scarpino A; Ferenczy GG; Keserű GM
Curr Pharm Des; 2020; 26(44):5684-5699. PubMed ID: 33155894
[TBL] [Abstract][Full Text] [Related]
10. New drug design with covalent modifiers.
Adeniyi AA; Muthusamy R; Soliman ME
Expert Opin Drug Discov; 2016; 11(1):79-90. PubMed ID: 26757171
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery for a new generation of covalent drugs.
Kalgutkar AS; Dalvie DK
Expert Opin Drug Discov; 2012 Jul; 7(7):561-81. PubMed ID: 22607458
[TBL] [Abstract][Full Text] [Related]
12. Advanced approaches of developing targeted covalent drugs.
Gai C; Harnor SJ; Zhang S; Cano C; Zhuang C; Zhao Q
RSC Med Chem; 2022 Dec; 13(12):1460-1475. PubMed ID: 36561076
[TBL] [Abstract][Full Text] [Related]
13. Can Precision Electrophile Signaling Make a Meaningful and Lasting Impression in Drug Design?
Long MJC; Kulkarni A; Aye Y
Chembiochem; 2022 Apr; 23(7):e202100051. PubMed ID: 33826211
[TBL] [Abstract][Full Text] [Related]
14. Where Electrophile Signaling and Covalent Ligand-Target Mining Converge.
Aye Y
Chimia (Aarau); 2020 Sep; 74(9):659-666. PubMed ID: 32958101
[TBL] [Abstract][Full Text] [Related]
15. Detection of electrophile-sensitive proteins.
Wall SB; Smith MR; Ricart K; Zhou F; Vayalil PK; Oh JY; Landar A
Biochim Biophys Acta; 2014 Feb; 1840(2):913-22. PubMed ID: 24021887
[TBL] [Abstract][Full Text] [Related]
16. Accelerating the Validation of Endogenous On-Target Engagement and In Cellulo Kinetic Assessment for Covalent Inhibitors of KRAS
Kantae V; Polanski R; Lewis HJ; Haider A; Barratt D; Srinivasan B
ACS Chem Biol; 2022 Aug; 17(8):2366-2376. PubMed ID: 35881961
[TBL] [Abstract][Full Text] [Related]
17. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
Li J; Wang G; Ye M; Qin H
Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
[TBL] [Abstract][Full Text] [Related]
18. Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices.
Oyedele AK; Ogunlana AT; Boyenle ID; Adeyemi AO; Rita TO; Adelusi TI; Abdul-Hammed M; Elegbeleye OE; Odunitan TT
Mol Divers; 2023 Aug; 27(4):1879-1903. PubMed ID: 36057867
[TBL] [Abstract][Full Text] [Related]
19. [Covalently bound residues: theoretical aspects].
Burgat-Sacaze V; Rico A
Ann Rech Vet; 1990; 21 Suppl 1():121S-127S. PubMed ID: 2080840
[TBL] [Abstract][Full Text] [Related]
20. Reactive chemistry for covalent probe and therapeutic development.
Grams RJ; Hsu KL
Trends Pharmacol Sci; 2022 Mar; 43(3):249-262. PubMed ID: 34998611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
